NUS NU Skin Enterprises (NUS) Insider Trading, Ownership & Congress Trades
Wholesale & Retail · Wholesale-drugs, proprietaries & druggists' sundries · CIK 0001021561
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
79
13F, latest reported quarter
What the filings say about NUS
Insiders, 180 days
-$99.5K net sold
3 sellers · 0% of sales under a 10b5-1 plan
NU Skin Enterprises insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, NU SKIN ENTERPRISES, INC. insiders sold a net $99.5K of stock across 90 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-29.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 19.2% of the 37,448 shares held after it.
- 2 other insiders sold within 30 days.
- 79 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Winett James M sold about $40.5K of NUS on Jun 2, 2026; 2 other insiders sold within 30 days and 79 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (3 sales), the last on Jun 2, 2025.
- The trade is 11.5% of the 62,433 shares held after it.
- 2 other insiders sold within 30 days.
- 79 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director WOODBURY EDWINA D sold about $41.1K of NUS on Jun 1, 2026; 2 other insiders sold within 30 days and 79 funds added in the latest 13F quarter.Context
- 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on Sep 4, 2025.
- The trade is 8.8% of the 30,473 shares held after it.
- 2 other insiders sold within 30 days.
- 79 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Nathanson Laura sold about $18.0K of NUS on May 11, 2026; 2 other insiders sold within 30 days and 79 funds added in the latest 13F quarter.Context
- 3 earlier Form 4 trades (code P or S) here by this insider (1 buy, 2 sales), the last on May 28, 2025.
- The trade is 3.3% of the 167,565 shares held after it.
- No other insider bought within 30 days.
- 79 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chief Product Officer Hatchett Steven Keith bought about $52.9K of NUS on Nov 11, 2025, the largest insider purchase at the company on our record; 79 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Aug 21, 2023.
- The trade is 19.6% of the 33,149 shares held after it.
- 2 other insiders sold within 30 days.
- 79 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Nathanson Laura sold about $79.3K of NUS on Sep 4, 2025; 2 other insiders sold within 30 days and 79 funds added in the latest 13F quarter.90 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
net -$99.5K over 180 days
more than 66% of Wholesale & Retail
Congress
no House purchase disclosed in the last 12 months
Funds
79 funds bought in last quarter
below 58% of Wholesale & Retail
Revenue
-14.3% year over year
below 85% of Wholesale & Retail
Margin
10.8% net margin
more than 92% of Wholesale & Retail
Buybacks
$5.0M repurchased, FY to 2026-06-30
below 75% of Wholesale & Retail
Short interest
9.6% of the float short (float per yahoo 2026-10-27) · 9.4 days to cover · settled 2026-10-15
more than 83% of Wholesale & Retail
What changed in the last 30 days
Oct 29Insider selling stopped: no sales in 90 days after 3 in the prior 90
Why it matters
The absence is the signal: 3 sales in one 90-day window and none in the next is a change of behaviour, not a filing.
Watch NUS
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
-56.1%12M
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns NUS: institutional holders (13F)
13F holdings, latest reported quarter
4,315,878 sh
$22.8M
2,301,308 sh
$12.2M
$11.3M
2,049,641 sh
$10.8M
1,796,745 sh
$9.5M
Congress trades in NUS
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
NUS planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
NUS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Cambria Micro and SmallCap Shareholder Yield ETF
$336.6K position · as of 2026-07-31
1.0%
Acquirers Small and Micro Deep Value ETF
$186.3K position · as of 2026-05-31
0.7%
First Trust Active Factor Small Cap ETF
$364.6K position · as of 2026-05-31
0.4%
First Trust Active Factor Mid Cap ETF
$598.6K position · as of 2026-05-31
0.4%
Franklin U.S. Small Cap Equity Fund
$244.5K position · as of 2026-06-30
0.2%
Inspire Small/Mid Cap ETF
$428.6K position · as of 2026-05-31
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Corporate PAC
The company's PAC: committee totals only, never individual donors (FEC).
Nu Skin Enterprises, Inc. Pac
Cycle 2026 · $0K spent
$0
Federal Election Commission, matched by the PAC's connected organisation
Executive pay vs shareholder return · Ryan SNapierski
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$6.0M
$1.7M
$2.1M
-85%
+40%
2023
$5.8M
$2.7M
$1.8M
-60%
+39%
2022
$4.8M
-$116.1K
$2.4M
-18%
+20%
2020
$6.6M
$18.1M
$2.6M
+39%
+11%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows a net $99.5K sold by insiders over 180 days, 79 funds added last quarter. Each figure is a federal filing, dated the day it went public.
NUS financials
Revenue growth
-14.3%
XBRL, annual
Net margin
10.8%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.4B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM NUS
| FY Dec 2025 | $1.5B |
| FY Dec 2024 | $1.7B |
| FY Dec 2023 | $2.0B |
| FY Dec 2022 | $2.2B |
| FY Dec 2021 | $2.7B |
| Jun 2026 | $320.1M |
| Mar 2026 | $320.6M |
| Dec 2025 | $370.3M |
| Sep 2025 | $364.2M |
| Jun 2025 | $386.1M |
| Mar 2025 | $364.5M |
| Dec 2024 | $445.6M |
| Sep 2024 | $430.1M |
At each fiscal year end
Single quarter
Net margin, TTM
-15.7%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM NUS
| FY Dec 2025 | +10.8% |
| FY Dec 2024 | -8.5% |
| FY Dec 2023 | +0.4% |
| FY Dec 2022 | +4.7% |
| FY Dec 2021 | +5.5% |
| Jun 2026 | -78.0% |
| Mar 2026 | +0.6% |
| Dec 2025 | +3.9% |
| Sep 2025 | +4.7% |
| Jun 2025 | +5.5% |
| Mar 2025 | +29.5% |
| Dec 2024 | -8.1% |
| Sep 2024 | +1.9% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$10.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM NUS
| FY Dec 2025 | $46.0M |
| FY Dec 2024 | $70.2M |
| FY Dec 2023 | $60.1M |
| FY Dec 2022 | $49.0M |
| FY Dec 2021 | $73.0M |
| Jun 2026 | $5.0M |
| Mar 2026 | -$17.6M |
| Dec 2025 | $5.9M |
| Sep 2025 | $17.6M |
| Jun 2025 | $35.8M |
| Mar 2025 | -$13.2M |
| Dec 2024 | $13.2M |
| Sep 2024 | $22.8M |
At each fiscal year end
Single quarter
Debt to equity
0.39x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity NUS
| FY Dec 2025 | 0.28x |
| FY Dec 2024 | 0.60x |
| FY Dec 2023 | 0.61x |
| FY Dec 2022 | 0.45x |
| FY Dec 2021 | 0.41x |
| Jun 2026 | 0.39x |
| Mar 2026 | 0.28x |
| Dec 2025 | 0.28x |
| Sep 2025 | 0.29x |
| Jun 2025 | 0.32x |
| Mar 2025 | 0.32x |
| Dec 2024 | 0.60x |
| Sep 2024 | 0.61x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.24x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt NUS
| FY Dec 2025 | 0.36x |
| FY Dec 2024 | 0.28x |
| FY Dec 2023 | 0.24x |
| FY Dec 2022 | 0.27x |
| FY Dec 2021 | 0.38x |
| Jun 2026 | 0.24x |
| Mar 2026 | 0.34x |
| Dec 2025 | 0.36x |
| Sep 2025 | 0.39x |
| Jun 2025 | 0.38x |
| Mar 2025 | 0.46x |
| Dec 2024 | 0.28x |
| Sep 2024 | 0.32x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
-32.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity NUS
| FY Dec 2025 | +22.0% |
| FY Dec 2024 | -19.9% |
| FY Dec 2023 | +1.0% |
| FY Dec 2022 | +11.6% |
| FY Dec 2021 | +16.3% |
| Jun 2026 | -32.5% |
| Mar 2026 | +7.0% |
| Dec 2025 | +22.0% |
| Sep 2025 | +14.5% |
| Jun 2025 | +13.7% |
| Mar 2025 | -4.9% |
| Dec 2024 | -19.9% |
| Sep 2024 | -13.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
-16.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets NUS
| FY Dec 2025 | +11.1% |
| FY Dec 2024 | -8.9% |
| FY Dec 2023 | +0.5% |
| FY Dec 2022 | +5.6% |
| FY Dec 2021 | +7.6% |
| Jun 2026 | -16.9% |
| Mar 2026 | +3.9% |
| Dec 2025 | +11.1% |
| Sep 2025 | +7.3% |
| Jun 2025 | +6.7% |
| Mar 2025 | -2.5% |
| Dec 2024 | -8.9% |
| Sep 2024 | -6.1% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
pre-tax loss, no effective tax rate to apply
Return on invested capital NUS
| FY Dec 2025 | +7.3% |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | +16.3% |
| Jun 2026 | n/a |
| Mar 2026 | +8.5% |
| Dec 2025 | +7.3% |
| Sep 2025 | -1.3% |
| Jun 2025 | -1.6% |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
-1.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed NUS
| FY Dec 2025 | +5.7% |
| FY Dec 2024 | -11.4% |
| FY Dec 2023 | +3.3% |
| FY Dec 2022 | +7.8% |
| FY Dec 2021 | +16.8% |
| Jun 2026 | -1.0% |
| Mar 2026 | +7.1% |
| Dec 2025 | +5.7% |
| Sep 2025 | -0.9% |
| Jun 2025 | -1.1% |
| Mar 2025 | -13.3% |
| Dec 2024 | -11.4% |
| Sep 2024 | -6.3% |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
P/E, trailing NUS
| FY Dec 2025 | 3.03x |
| FY Dec 2024 | n/a |
| FY Dec 2023 | 114.24x |
| FY Dec 2022 | 20.57x |
| FY Dec 2021 | 17.74x |
| Jun 2026 | n/a |
| Mar 2026 | 6.74x |
| Dec 2025 | 3.03x |
| Sep 2025 | 5.57x |
| Jun 2025 | 3.96x |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$254.3M
market value at close 2026-10-27 on 2026-07-31 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value NUS
| FY Dec 2025 | $454.5M |
| FY Dec 2024 | $549.2M |
| FY Dec 2023 | $1.2B |
| FY Dec 2022 | $2.2B |
| FY Dec 2021 | $2.6B |
| Jun 2026 | $280.4M |
| Mar 2026 | $375.3M |
| Dec 2025 | $454.5M |
| Sep 2025 | $580.6M |
| Jun 2025 | $379.6M |
| Mar 2025 | $396.0M |
| Dec 2024 | $549.2M |
| Sep 2024 | $572.0M |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+4.7%
TTM free cash flow over market value at close 2026-10-27
FCF yield NUS
| FY Dec 2025 | +9.8% |
| FY Dec 2024 | +20.5% |
| FY Dec 2023 | +6.3% |
| FY Dec 2022 | +2.4% |
| FY Dec 2021 | +2.9% |
| Jun 2026 | +4.2% |
| Mar 2026 | +11.9% |
| Dec 2025 | +9.8% |
| Sep 2025 | +8.8% |
| Jun 2025 | +14.8% |
| Mar 2025 | +18.3% |
| Dec 2024 | +20.5% |
| Sep 2024 | +24.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing loss, a multiple of a loss is not meaningful
PEG, trailing NUS
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $1.5B | $1.7B | $2.0B | $2.2B |
| Gross profit | $1.0B | $1.2B | $1.4B | $1.6B |
| Operating income | $65.8M | -$151.6M | $48.3M | $110.8M |
| Net income | $160.2M | -$146.6M | $8.6M | $104.8M |
| EPS (diluted) | 3.18 | -2.95 | 0.17 | 2.07 |
| Operating cash flow | $80.3M | $111.7M | $118.6M | $108.1M |
| Cash | $238.6M | $186.9M | $256.1M | $264.7M |
| Long-term debt | $204.2M | $363.6M | $478.0M | $377.5M |
| Buybacks | $20.0M | $0 | $13.0M | $70.0M |
| Dividends paid | $11.8M | $11.9M | $77.6M | $77.0M |
SEC XBRL, fiscal years, as known on 2026-10-29
NUS Stock Sonar score 6/7 axes
Find similar shapesCompareNUS ranks highest on risk and compliance (54th percentile) and financial health (47th), and lowest on growth (15th), among Wholesale & Retail peers.
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
NUS filings, in plain words
Are NU Skin Enterprises insiders buying or selling NUS?
In the 180 days to 2026-10-29, NU Skin Enterprises insiders were net sellers, a net $99.5K across purchases and sales reported on Form 4, by 3 sellers.
Read the full summary
In the 180 days to 2026-10-29, NU Skin Enterprises insiders were net sellers of NUS, a net $99.5K across purchases and sales reported on Form 4 by 3 sellers. None of the 3 insider sales was flagged as made under a Rule 10b5-1 plan. Each figure is counted from SEC and House filings as of 2026-10-29, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
